1.03

1.90% -0.02

After Hours: 1.07 0.04 +3.88%

Mainz Biomed N V (MYNZ)

Overview News Price History Why MYNZ Down? Discussions Forecast

Mainz Biomed N V stock is traded at $1.03, with a volume of 195.13K. It is down -1.90% in the last 24 hours and down -24.26% over the past month. Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Previous Close:

$1.05

Open:

$1.04

24h Volume:

195.13K

Relative Volume:

0.41

Market Cap:

$8.84M

Revenue:

$895.50K

Net Income/Loss:

$-26.30M

P/E Ratio:

-0.0157

EPS:

-65.5728

Net Cash Flow:

$-23.84M

1W Performance:

-11.21%

1M Performance:

-24.26%

6M Performance:

-48.24%

1Y Performance:

-81.61%

1-Day Range:

$0.995

$1.07

1-Week Range:

$0.995

$1.17

52-Week Range:

$0.92

$8.20

Mainz Biomed N V Stock (MYNZ) Company Profile

Name

Mainz Biomed N V

Sector

Healthcare (1123)

Industry

Diagnostics & Research (53)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-09-03

Latest SEC Filings

MYNZ's Discussions on Twitter

Compare MYNZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MYNZ Mainz Biomed N V	1.03	9.01M	895.50K	-26.30M	-23.84M	-65.57
TMO Thermo Fisher Scientific Inc	572.28	217.50B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	226.33	164.13B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	704.20	56.49B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	139.68	40.44B	6.95B	1.30B	1.15B	4.5714
IQV Iqvia Holdings Inc	222.26	38.48B	15.90B	1.28B	2.21B	7.2842

Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-14-25	Initiated	Maxim Group	Buy
Nov-25-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-21-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-21-22	Initiated	H.C. Wainwright	Buy

Mainz Biomed N V Stock (MYNZ) Latest News

01:14 AM

2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com

01:14 AM

09:54 AM

2 Small-Cap Biotechs That Could Reward Patient Investors - MarketBeat

09:54 AM

Dec 05, 2025

Is Mainz Biomed N.V. stock positioned for long term growthJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser

Dec 05, 2025

Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsWeekly Market Outlook & Stock Portfolio Risk Control - Newser

Dec 05, 2025

Dec 04, 2025

Can Mainz Biomed N.V. (4TO) stock sustain free cash flow2025 Top Gainers & Fast Moving Stock Trade Plans - Newser

Dec 04, 2025

Dec 03, 2025

Is Mainz Biomed N.V. (4TO) stock expanding market penetrationJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser

Dec 03, 2025

Why Mainz Biomed N.V. (4TO) stock is favored by hedge fundsProduct Launch & Weekly High Conviction Ideas - Newser

Dec 03, 2025

Dec 02, 2025

Mainz Biomed (MYNZ) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Mainz Biomed (NASDAQ: MYNZ) brings ColoAlert to DoctorBox for colorectal screening - Stock Titan

Dec 02, 2025

Nov 29, 2025

Weekly Trades: Why hedge funds are buying Mainz Biomed N.V. stockJobs Report & Reliable Price Breakout Alerts - moha.gov.vn

Nov 29, 2025

Nov 27, 2025